Has-miR-875-5p Inhibits Tumorigenesis by Targeting USF2 via TGF-β Signaling Pathway in Gastric Cancer

Shenshuo Gao(Shandong University), Xiaobo Guo(Capital Medical University), Chensheng Li(Sun Yat-sen University), Xubin Wang(Shandong Provincial Hospital), Zhikai Zhang(Shandong Institute of Business and Technology), Hongjun Liu(Jiaxing University), Leping Li(Shandong University), Yan Ma(Shandong Provincial Hospital), Changqing Jing(Shandong Provincial Hospital)
Research Square
September 20, 2021
10.21203/rs.3.rs-885737/v1
Cited by 0

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
The structure of the C‐terminal actin‐binding domain of talin
|The EMBO Journal|2007|205
Wnt Signaling Regulates Hepatic Metabolism
|Science Signaling|2011|172
Three-Dimensional Structure of Vinculin Bound to Actin Filaments
|Molecular Cell|2006|146
Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study
|World Journal of Surgical Oncology|2017|137